Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH

NCT02820285 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Non Alcoholic Fatty Liver Disease

Interventions

OTHER: Evaluation of the staging of fibrosis liver
OTHER: Determine the expression level of semaphorin
OTHER: Determination of the composition of immunity cells

Sponsor

Centre Hospitalier Universitaire de Nice